Concepedia

Stuart Ray

SR

Statistics

Publications

8

Citations

872

H-Index

8

Active since

2007

Affiliations

Granta Design (United Kingdom)(Current)

Lundbeck (Denmark)

Servier (France)

Stuart Ray is an author at Granta Design (United Kingdom) specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

2007–2021

8

Publications

8

4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

Paul A. Brough, Wynne Aherne, Xavier Barril et al. · Journal of Medicinal Chemistry · 2007 · 445 citations · Full text

, , +11

Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution

Andrew Potter, Victoria Oldfield, Claire L. Nunns et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 97 citations · Full text

, , +13

Structure-guided design of α-amino acid-derived Pin1 inhibitors

Andrew Potter, Stuart Ray, Louisa Gueritz et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 86 citations · Full text

, , +14

Establishing Drug Discovery and Identification of Hit Series for the Anti-apoptotic Proteins, Bcl-2 and Mcl-1

James B. Murray, James Davidson, I‐Jen Chen et al. · ACS Omega · 2019 · 72 citations · Full text

, , +17

Design of Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Crystallographic Surrogate Derived from Checkpoint Kinase 1 (CHK1)

D.S. Williamson, Garrick P. Smith, P. Acheson-Dossang et al. · Journal of Medicinal Chemistry · 2017 · 47 citations · Full text

, , +15

1–5 of 8